Multiple sclerosis, Lancet Lond Engl. 6 avr, vol.359, issue.9313, pp.1221-1252, 2002. ,
URL : https://hal.archives-ouvertes.fr/hal-00996686
Geographical Variations in Sex Ratio Trends over Time in Multiple Sclerosis, vol.7, 2012. ,
The changing demographic pattern of multiple sclerosis epidemiology, Lancet Neurol. mai, vol.9, issue.5, pp.520-552, 2010. ,
Cognitive dysfunction in multiple sclerosis. II. Impact on employment and social functioning, Neurology. mai, vol.41, issue.5, pp.692-698, 1991. ,
The cost burden of multiple sclerosis in the United States: a systematic review of the literature, J Med Econ, vol.16, issue.5, pp.639-686, 2013. ,
, Rev Neurol (Paris). juill, vol.170, issue.6-7, pp.432-441, 2014.
A reassessment of the distribution of multiple sclerosis. Part one, Acta Neurol Scand. févr, vol.51, issue.2, pp.110-146, 1975. ,
Environmental risk factors in multiple sclerosis aetiology, Lancet Neurol. déc, vol.3, issue.12, pp.709-727, 2004. ,
Geographic variations of multiple sclerosis in France, Brain. 1 juill, vol.133, issue.7, pp.1889-99, 2010. ,
Regional variations in the prevalence of multiple sclerosis in French farmers, J Neurol Neurosurg Psychiatry. juill, vol.78, issue.7, pp.707-716, 2007. ,
Problems of experimental trials of therapy in multiple sclerosis : report by the panel on the evaluation of experimental trials of therapy in multiple sclerosis ,
, Ann N Y Acad Sci. 31 mars, vol.122, pp.552-68, 1965.
Defining the clinical course of multiple sclerosis: results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis, Neurology. avr, vol.46, issue.4, pp.907-918, 1996. ,
Onset of secondary progressive phase and long-term evolution of multiple sclerosis, J Neurol Neurosurg Psychiatry. janv, vol.85, issue.1, pp.67-75, 2014. ,
Clinical and MRI characterization of MS patients with a pure and severe cognitive onset, Clin Neurol Neurosurg, vol.126, pp.55-63, 2014. ,
URL : https://hal.archives-ouvertes.fr/hal-01251574
Cognitive impairment in multiple sclerosis, Curr Opin Neurol. juin, vol.20, issue.3, p.275, 2007. ,
Relapses and progression of disability in multiple sclerosis, N Engl J Med, vol.343, issue.20, pp.1430-1438, 2000. ,
Axonal transection in the lesions of multiple sclerosis, N Engl J Med. 29 janv, vol.338, issue.5, pp.278-85, 1998. ,
Evidence for pathogenic heterogeneity in multiple sclerosis, Ann Neurol. août, vol.56, issue.2, p.308, 2004. ,
Immunopathology of multiple sclerosis, Nat Rev Immunol. 15 sept, vol.15, issue.9, pp.545-58, 2015. ,
A basic overview of multiple sclerosis immunopathology, Eur J Neurol. oct, vol.22, issue.2, pp.3-13, 2015. ,
Autoimmune T cell responses in the central nervous system, Nat Rev Immunol. juin, vol.9, issue.6, p.393, 2009. ,
Infectious mononucleosis and risk for multiple sclerosis: a meta-analysis, Ann Neurol. mars, vol.59, issue.3, pp.499-503, 2006. ,
Environmental risk factors for multiple sclerosis. Part I: the role of infection, Ann Neurol. avr, vol.61, issue.4, pp.288-99, 2007. ,
Environmental risk factors for multiple sclerosis. Part II: Noninfectious factors, Ann Neurol. juin, vol.61, issue.6, pp.504-517, 2007. ,
Smoking is a risk factor for multiple sclerosis: a metanalysis, Mult Scler Houndmills Basingstoke Engl. juin, vol.13, issue.5, pp.610-615, 2007. ,
Past exposure to sun, skin phenotype, and risk of multiple sclerosis: casecontrol study, BMJ. 9 août, vol.327, issue.7410, p.316, 2003. ,
Association of UV radiation with multiple sclerosis prevalence and sex ratio in France, Neurology. 1 févr, vol.76, issue.5, pp.425-456, 2011. ,
URL : https://hal.archives-ouvertes.fr/hal-00567871
Is hypovitaminosis D one of the environmental risk factors for multiple sclerosis?, Brain J Neurol. juill, vol.133, pp.1869-88, 2010. ,
Genotype-Phenotype correlations in multiple sclerosis: HLA genes Page, vol.85, p.95 ,
, influence disease severity inferred by 1HMR spectroscopy and MRI measures, Brain. janv, vol.132, issue.1, pp.250-259, 2009.
Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis, Nature. 10 août, vol.476, issue.7359, pp.214-223, 2011. ,
URL : https://hal.archives-ouvertes.fr/hal-00996686
Variants in the IL7RA gene confer susceptibility to multiple sclerosis in Caucasians: evidence based on 9734 cases and 10436 controls, vol.7, 2017. ,
The natural history of multiple sclerosis: a geographically based study. 2. Predictive value of the early clinical course, Brain J Neurol. déc, vol.112, pp.1419-1447, 1989. ,
Early clinical predictors and progression of irreversible disability in multiple sclerosis: an amnesic process, Brain J Neurol. avr, vol.126, pp.770-82, 2003. ,
URL : https://hal.archives-ouvertes.fr/hal-00427394
A longitudinal study of abnormalities on MRI and disability from multiple sclerosis, N Engl J Med. 17 janv, vol.346, issue.3, pp.158-64, 2002. ,
Prognostic indicators for long-term disability in multiple sclerosis patients, J Neurol Sci. 15 janv, vol.324, issue.1-2, pp.29-33, 2013. ,
The incidence of clinically isolated syndrome in a multi-ethnic cohort, J Neurol. juill, vol.261, issue.7, pp.1349-55, 2014. ,
Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS), Neurology. nov, vol.33, issue.11, pp.1444-52, 1983. ,
Evidence for a two-stage disability progression in multiple sclerosis, Brain. juill, vol.133, issue.7, pp.1900-1913, 2010. ,
,
, Rev Prat. 30 juin, vol.56, issue.12, pp.1313-1333, 2006.
Evaluation of no evidence of disease activity in a 7-year longitudinal multiple sclerosis cohort, JAMA Neurol. févr, vol.72, issue.2, pp.152-160, 2015. ,
Natural history of multiple sclerosis in a population-based cohort, Eur J Neurol. sept, vol.15, issue.9, pp.916-937, 2008. ,
The window of therapeutic opportunity in multiple sclerosis: evidence from monoclonal antibody therapy, J Neurol. janv, vol.253, issue.1, pp.98-108, 2006. ,
, Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. I. Clinical results of a multicenter, randomized, double-blind, placebo-controlled trial. The IFNB Multiple Sclerosis Study Group, Neurology. avr, vol.43, issue.4, pp.655-61, 1993.
Copolymer 1 reduces relapse rate and improves disability in relapsing-remitting multiple sclerosis: results of a phase III multicenter, double-blind placebocontrolled trial. The Copolymer 1 Multiple Sclerosis Study Group, Neurology. juill, vol.45, issue.7, pp.1268-76, 1995. ,
Treatment with interferon beta-1b delays conversion to clinically definite and McDonald MS in patients with clinically isolated syndromes, Neurology, vol.67, issue.7, pp.1242-1251, 2006. ,
Induction Therapy for Patients with Multiple Sclerosis: Why? When? How?, CNS Drugs, vol.27, issue.6, pp.403-412, 2013. ,
URL : https://hal.archives-ouvertes.fr/hal-00877114
A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis, N Engl J Med. 2 mars, vol.354, issue.9, pp.899-910, 2006. ,
Previous treatment influences fingolimod efficacy in relapsing-remitting multiple sclerosis: results from an observational study, Curr Med Res Opin. sept, vol.30, issue.9, pp.1849-55, 2014. ,
Mitoxantrone as induction treatment in aggressive relapsing remitting multiple sclerosis: treatment response factors in a 5 year follow-up observational study of 100 consecutive patients, J Neurol Neurosurg Psychiatry. janv, vol.79, issue.1, pp.52-58, 2008. ,
Oral versus intravenous high-dose methylprednisolone for treatment of relapses in patients with multiple sclerosis (COPOUSEP): a randomised, controlled, double-blind, non-inferiority trial, Lancet Lond Engl. 5 sept, vol.386, issue.9997, pp.974-81, 2015. ,
Corticosteroids or ACTH for acute exacerbations in multiple sclerosis, Cochrane Database Syst Rev, issue.4, p.1331, 2000. ,
The diagnostic criteria for multiple sclerosis: From Charcot to McDonald, Mult Scler Relat Disord. janv, vol.1, issue.1, pp.9-14, 2012. ,
New diagnostic criteria for multiple sclerosis: guidelines for research protocols, Ann Neurol. mars, vol.13, issue.3, pp.227-258, 1983. ,
Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis, Ann Neurol. juill, vol.50, issue.1, pp.121-128, 2001. ,
New diagnostic criteria for multiple sclerosis: application in first demyelinating episode, Neurology. 14 janv, vol.60, issue.1, pp.27-30, 2003. ,
Comparison of MRI criteria at first presentation to predict conversion to clinically definite multiple sclerosis, Brain J Neurol, vol.120, pp.2059-69, 1997. ,
Cerebrospinal fluid in the diagnosis of multiple sclerosis: a consensus report, J Neurol Neurosurg Psychiatry. août, vol.57, issue.8, pp.897-902, 1994. ,
Diagnostic criteria for multiple sclerosis: 2005 revisions to the « McDonald Criteria, Ann Neurol. déc, vol.58, issue.6, pp.840-846, 2005. ,
MRI criteria for multiple sclerosis in patients presenting with clinically isolated syndromes: a multicentre retrospective study, Lancet Neurol. août, vol.6, issue.8, pp.677-86, 2007. ,
Multiple sclerosis in the Japanese population, Lancet Neurol. févr, vol.2, issue.2, pp.117-144, 2003. ,
Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria, Ann Neurol. févr, vol.69, issue.2, pp.292-302, 2011. ,
Cerebrospinal fluid oligoclonal bands are important in the diagnosis of multiple sclerosis, unreasonably downplayed by the McDonald criteria 2010: Yes, Mult Scler Houndmills Basingstoke Engl. mai, vol.19, issue.6, pp.714-720, 2013. ,
Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria, Lancet Neurol. févr, vol.17, issue.2, pp.162-73, 2018. ,
Diagnosis of multiple sclerosis: revision of the McDonald criteria, Nervenarzt. 6 juin, 2017. ,
The natural history of multiple sclerosis: a geographically based study. I. Clinical course and disability, Brain J Neurol. févr, vol.112, pp.133-179, 1989. ,
Disability progression in multiple sclerosis is slower than previously reported, Neurology. 24 janv, vol.66, issue.2, pp.172-179, 2006. ,
Multiple sclerosis, Lancet Lond Engl, vol.372, issue.9648, pp.1502-1519, 2008. ,
URL : https://hal.archives-ouvertes.fr/hal-00996686
Modification of Multiple Sclerosis Phenotypes by African Ancestry at HLA, Arch Neurol. févr, vol.66, issue.2, pp.226-259, 2009. ,
Comparisons of Latinos, African Americans, and Caucasians with multiple sclerosis, Ethn Dis, vol.20, issue.4, pp.451-458, 2010. ,
Clinical characteristics of African Americans vs Caucasian Americans with multiple sclerosis, Neurology. 14 déc, vol.63, issue.11, pp.2039-2084, 2004. ,
, , 2005.
, McDonald MRI criteria for dissemination in space in Afro-Caribbean patients with clinically isolated syndromes, Eur J Neurol, vol.16, issue.11, pp.1191-1197, 2009.
Multiple sclerosis in gulf war era veterans. 2. Military deployment and risk of multiple sclerosis in the first gulf war, Neuroepidemiology, vol.42, issue.4, pp.226-260, 2014. ,
Phenotype and prognosis in African-Americans with multiple sclerosis: a retrospective chart review, Mult Scler Houndmills Basingstoke Engl. déc, vol.12, issue.6, pp.775-81, 2006. ,
Multiple sclerosis: severity and progression rate in African Americans compared with whites, Am J Phys Med Rehabil. août, vol.82, issue.8, pp.582-90, 2003. ,
Differential Impact of Multiple Sclerosis on Cortical and Deep Gray Matter Structures in African Americans and Caucasian Americans, J Neuroimaging Off J Am Soc Neuroimaging. mai, vol.27, issue.3, pp.333-341, 2017. ,
The Gulf War era multiple sclerosis cohort: 3. Early clinical features, Acta Neurol Scand. janv, vol.137, issue.1, pp.76-84, 2018. ,
Multiple Sclerosis Severity Score: using disability and disease duration to rate disease severity, Neurology. 12 avr, vol.64, issue.7, pp.1144-51, 2005. ,
Rapid disease course in African Americans with multiple sclerosis, Neurology. 20 juill, vol.75, issue.3, pp.217-240, 2010. ,
Pediatriconset multiple sclerosis in African-American black and European-origin white patients, Pediatr Neurol. janv, vol.40, issue.1, pp.31-34, 2009. ,
Retinal Damage and Vision Loss in African-American Multiple Sclerosis Patients, Ann Neurol. févr, vol.77, issue.2, pp.228-264, 2015. ,
Visual phenotype of multiple sclerosis in the Afro-Caribbean population and the influence of migration to metropolitan France, Eur J Ophthalmol. juin, vol.15, issue.3, pp.392-401, 2005. ,
Optic neuritis in African Americans, Arch Neurol. févr, vol.55, issue.2, pp.186-92, 1998. ,
Characterizing retinal structure injury in African-Americans with multiple sclerosis, Mult Scler Relat Disord. mai, vol.7, pp.16-20, 2016. ,
Role of return migration in the emergence of multiple sclerosis in the French West Indies, Brain J Neurol. déc, vol.128, pp.2899-910, 2005. ,
Migration and multiple sclerosis: the French West Indies experience, J Neurol Sci, vol.15, issue.1-2, pp.117-138, 2007. ,
,
, Bull Soc Pathol Exot, vol.86, issue.5, pp.428-460, 1990.
Endemic tropical spastic paraparesis associated with human T-lymphotropic virus type I: a clinical and seroepidemiological study of 25 cases, Ann Neurol. févr, vol.21, issue.2, pp.123-153, 1987. ,
MS and neuromyelitis optica in Martinique (French West Indies), Neurology. 27 févr, vol.56, issue.4, pp.507-521, 2001. ,
Environmental changes and epidemiology of multiple sclerosis in the French West Indies, J Neurol Sci, vol.15, issue.1-2, pp.58-61, 2009. ,
Multiple sclerosis in the Faroe Islands and the lack of protection by exposure in infancy, Neuroepidemiology, vol.11, issue.2, pp.90-99, 1992. ,
,
, Bull Soc Pathol Exot Filiales. oct, vol.76, issue.4, pp.406-422, 1983.
CD25+CD4+ cells contribute to Th2 polarization during helminth infection by suppressing Th1 response development, J Immunol Baltim Md, vol.173, issue.2, pp.1224-1255, 1950. ,
Multiple sclerosis and solar exposure before the age of 15 years: case-control study in Cuba, Martinique and Sicily, Mult Scler Houndmills Basingstoke Engl. août, vol.16, issue.8, pp.899-908, 2010. ,
URL : https://hal.archives-ouvertes.fr/hal-00606425
Vitamin D3 Confers Protection from Autoimmune Encephalomyelitis Only in Female Mice, J Immunol. 15 sept, vol.175, issue.6, pp.4119-4145, 2005. ,
The pattern of neurological illness in tropical Africa. Experience at Ibadan, Nigeria, J Neurol Sci. avr, vol.12, issue.4, pp.417-459, 1971. ,
Multiple sclerosis and neuromyelitis optica. Case report and speculation, South Afr Med J Suid-Afr Tydskr Vir Geneeskd. 8 août, vol.60, issue.6, pp.249-51, 1981. ,
Demyelinating disorder of the central nervous system occurring in black South Africans, J Neurol Neurosurg Psychiatry. avr, vol.70, issue.4, pp.500-505, 2001. ,
Multiple sclerosis in KwaZulu Natal, South Africa: an epidemiological and clinical study, vol.13, pp.1095-1104, 2007. ,
Increased tissue damage and lesion volumes in African Americans with multiple sclerosis, Neurology. 16 févr, vol.74, issue.7, pp.538-582, 2010. ,
Ethnic Considerations and Multiple Sclerosis Disease Variability in the United States, Neurol Clin. févr, vol.36, issue.1, pp.151-62, 2018. ,
International consensus diagnostic criteria for neuromyelitis optica spectrum disorders, Neurology. 14 juill, vol.85, issue.2, pp.177-89, 2015. ,
EDMUS, a European database for multiple sclerosis, J Neurol Neurosurg Psychiatry. août, vol.55, issue.8, pp.671-677, 1992. ,
Incidence of multiple sclerosis in multiple racial and ethnic groups, Neurology. 7 mai, vol.80, pp.1734-1743, 2013. ,
MRI Correlates of Disability in African-Americans with Multiple Sclerosis, PLoS ONE. 10 août, vol.7, issue.8, 2012. ,
Higher IgG index found in African Americans versus Caucasians with multiple sclerosis, Neurology. 3 juill, vol.69, issue.1, pp.68-72, 2007. ,
Cerebral Gray Matter Atrophy Is Associated with the CSF IgG index in African American with Multiple Sclerosis, J Neuroimaging Off J Am Soc Neuroimaging. sept, vol.27, issue.5, pp.476-80, 2017. ,
Temporal changes and geographical differences in multiple sclerosis phenotypes in Japanese: nationwide survey results over 30 years, Mult Scler Houndmills Basingstoke Engl. févr, vol.15, issue.2, pp.159-73, 2009. ,
Criteria for an increased specificity of MRI interpretation in elderly subjects with suspected multiple sclerosis, Neurology. déc, vol.38, issue.12, pp.1822-1827, 1988. ,
Converting relapsing remitting to secondary progressive experimental allergic encephalomyelitis (EAE) by ultraviolet B irradiation, J Neuroimmunol. mars, vol.160, issue.1-2, pp.122-156, 2005. ,
Age at immigration to England of Asian and Caribbean immigrants and the risk of developing multiple sclerosis, J Neurol Neurosurg Psychiatry, vol.63, issue.5, pp.565-573, 1997. ,
The age-range of risk of developing multiple sclerosis: evidence from a migrant population in Australia, Brain J Neurol. mai, vol.123, pp.968-74, 2000. ,
Clinical features of multiple sclerosis in a genetically homogeneous tropical population, Mult Scler Houndmills Basingstoke Engl. août, vol.7, issue.4, pp.227-236, 2001. ,
Multiple sclerosis among the United Kingdom-born children of immigrants from the West Indies, J Neurol Neurosurg Psychiatry. mars, vol.50, issue.3, pp.327-359, 1987. ,
Prevalence of multiple sclerosis among immigrants in Norway, Mult Scler Houndmills Basingstoke Engl. mai, vol.21, issue.6, pp.695-702, 2015. ,
Generational changes in multiple sclerosis phenotype in North African immigrants in France: A population-based observational study, PLoS ONE. 27 mars, vol.13, issue.3, 2018. ,
URL : https://hal.archives-ouvertes.fr/hal-02361080
Fast multiple sclerosis progression in North Africans: Both genetics and environment matter, Neurology. 28 mars, vol.88, issue.13, pp.1218-1243, 2017. ,
Risk alleles for multiple sclerosis identified by a genomewide study, N Engl J Med, vol.357, issue.9, pp.851-62, 2007. ,
Multiple Sclerosis in Latin Americans: Genetic Aspects, Curr Neurol Neurosci Rep. août, vol.17, issue.8, p.57, 2017. ,
Genetic risk variants in African Americans with multiple sclerosis, Neurology. 16 juill, vol.81, issue.3, pp.219-246, 2013. ,
An ImmunoChip study of multiple sclerosis risk in African Americans, Brain. juin, vol.138, issue.6, pp.1518-1548, 2015. ,
Genetic and functional studies in multiple sclerosis patients from Martinique attest for a specific and direct role of the HLA-DR locus in the syndrome, Tissue Antigens. févr, vol.61, issue.2, pp.166-71, 2003. ,
The Genetic Structure and History of Africans and African Americans, Science. mai, vol.324, issue.5930, pp.1035-1079, 2009. ,
Mapping Multiple Sclerosis Susceptibility to the HLA-DR Locus in African Americans, Am J Hum Genet. janv, vol.74, issue.1, pp.160-167, 2004. ,
Multiple sclerosis susceptibility alleles in African Americans, Genes Immun. juin, vol.11, issue.4, pp.343-50, 2010. ,
Epigenetic changes in patients with multiple sclerosis, Nat Rev Neurol. janv, vol.9, issue.1, pp.35-43, 2013. ,
Response to Interferon-Beta Treatment in Afro-Caribbeans with Multiple Sclerosis, Mult Scler Int, 2011. ,
Response to interferon beta-1a treatment in African American multiple sclerosis patients, Arch Neurol, vol.62, issue.11, pp.1681-1684, 2005. ,
Efficacy and tolerability of dimethyl fumarate in White-, African-and Hispanic-Americans with multiple sclerosis, Ther Adv Neurol Disord, vol.9, issue.6, pp.454-61, 2016. ,
Efficacy of natalizumab therapy in patients of African descent with relapsing multiple sclerosis: analysis of AFFIRM and SENTINEL data, Arch Neurol. avr, vol.68, issue.4, pp.464-472, 2011. ,
Response to natalizumab treatment in Afro-Caribbean with multiple sclerosis ,
Phase IV study of retention on fingolimod versus injectable multiple sclerosis therapies: a randomized clinical trial, Ther Adv Neurol Disord, vol.11, p.1756286418774338, 2018. ,
,
, Au moment d'être admis à exercer la médecine, je promets et je jure d'être fidèle aux lois de l'honneur et de la probité
, Mon premier souci sera de rétablir, de préserver ou de promouvoir la santé dans tous ses éléments, physiques et mentaux, individuels et sociaux
, Je respecterai toutes les personnes, leur autonomie et leur volonté, sans aucune discrimination selon leur état ou leurs convictions. J'interviendrai pour les protéger si elles sont affaiblies
, Même sous la contrainte, je ne ferai pas usage de mes connaissances contre les lois de l'humanité
, Je ne tromperai jamais leur confiance et n'exploiterai pas le pouvoir hérité des circonstances pour forcer les consciences
, Je ne me laisserai pas influencer par la soif du gain ou la recherche de la gloire
, Admis dans l'intimité des personnes, je tairai les secrets qui me seront confiés
, Reçu à l'intérieur des maisons, je respecterai les secrets des foyers et ma conduite ne servira pas à corrompre les moeurs
, Je ne prolongerai pas abusivement les agonies. Je ne provoquerai jamais la mort délibérément
, Je préserverai l'indépendance nécessaire à l'accomplissement de ma mission
, Je les entretiendrai et les, perfectionnerai pour assurer au mieux les services qui me seront demandés
, J'apporterai mon aide à mes confrères ainsi qu'à leurs familles dans l'adversité
, Que les hommes et mes confrères m'accordent leur estime si je suis fidèle à mes promesses ; que je sois déshonoré et méprisé si j'y manque